Bioanalysis

With over 30 years of expertise to examine drug concentration in biological samples (bioanalysis) for nonclinical and clinical studies, SCAS offers high-quality and rapid services, including analytical method development, method validation, and sample measurements across various modalities, while addressing our client needs.

• GLP- and ICH M10-Compliant Bioanalysis for a Wide Range of Modalities in Nonclinical and Clinical Studies
  
• Wide Range of Bioanalysis and Immunogenicity Assessment Services for Large-Molecule Drugs
  
• Bioanalysis of Antibody-Drug Conjugates (ADCs)
  
• Bioanalysis for Biopharmaceuticals Using the Gyrolab™ xP Workstation
  
• Analytical Method Development for Antibody-Based Drugs in Biological Samples using LC-MS/MS
  
• Bioanalysis for Oligonucleotides Using Low-Adsorption LC–MS/MS
  
• Bioanalysis for Peptide Drugs Using Low-Adsorption LC–MS/MS
  
• Bioanalysis for Small-Molecule Drugs Using LC–MS/MS
  
• Analytical Support on Drug-Drug Interaction Evaluation for your Clinical Development